Novel antigens of CAR T cell therapy: New roads; old destination

Chimeric antigen receptor T cell (CAR-T) therapy has so far proved itself as a reliable therapeutic option for the treatment of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), and mantle cell lymphoma (MCL). However...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarzadeh Kozani, Pooria, Safarzadeh Kozani, Pouya, Rahbarizadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065293/
https://www.ncbi.nlm.nih.gov/pubmed/33862524
http://dx.doi.org/10.1016/j.tranon.2021.101079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065293/
https://www.ncbi.nlm.nih.gov/pubmed/33862524
http://dx.doi.org/10.1016/j.tranon.2021.101079

Ejemplares similares